3 days ago
Concord Biotech Ltd. (CONCORDBIO) Receives a Hold from Jefferies
Jefferies analyst Alok Dalal maintained a Hold rating on Concord Biotech Ltd. (CONCORDBIO – Research Report) today and set a price target of INR1,700.00. The company's shares closed yesterday at INR1,748.50.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Dalal covers the Healthcare sector, focusing on stocks such as Ajanta Pharma Limited, Cipla Ltd, and Concord Biotech Ltd.. According to TipRanks, Dalal has an average return of 2.2% and a 55.17% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Concord Biotech Ltd..
